Pharma Excipients

News on Pharma Excipients

Low drug load, high retention mometasone furoate cream with polyglyceryl − 3 oleate as a chemical enhancer: Formulation development, in vivo and in vitro evaluation and molecular mechanisms

Abstract The study aimed to create a low loading, high retention, easier to apply O/W mometasone furoate (MF) cream using a chemical enhancer (CE) approach to provide more options for patients with atopic dermatitis (AD) and to investigate molecular mechanisms of its increased release and retention. A Box-Behnken design determined the optimal…

21. April 2015 No Room for Boredom: What’s New in Pharmaceutical Excipients Nicole Buist, Ph.D. is a principal scientist in the Discovery Pharmaceutical Sciences department at Merck & Co., Inc. She is also the 2015…

Lactose Excipients by Armor Pharma

15. April 2015 Our quest for excellence has led us to a sustainable level of product development : a structured range of lactose for the formulation of Oral Solid Dosage Forms and Dry Powder Inhalers, which…

GMPs for Excipient Makers Move Ahead

15. April 2015 The FDA is edging toward requiring pharmaceutical excipient makers to adopt quality systems and has collaborated with standards development groups in…

Direct compression of medicated chewing gum

08. April 2015 Article published in Tablets & Capsules in January 2013 In this edition of the column, Javier Belmar and Marc Ribé of Cafosa discuss the formulation and manufacture of direct-compression medicated…